Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports

Viral Infections, Non-HIV

Cancer associates with risk and severe events of COVID-19: A systematic review and meta-analysis

Int J Cancer.

Tian Y, Qiu X, Wang C, Zhao J, Jiang X, Niu W, Huang J, Zhang F

doi: 10.1002/ijc.33213.

Viral Infections, Non-HIV

Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Lancet.

Mehra MR, Desai SS, Ruschitzka F, Patel AN

doi: 10.1016/S0140-6736(20)31180-6.

Viral Infections, Non-HIV

Clinical outcomes and adverse events in patients hospitalised with COVID -19, treated with off- label hydroxychloroquine and azithromycin

Br J Clin Pharmacol.

Kelly M, O'Connor R, Townsend L, Coghlan M, Relihan E, Moriarty M, Carr B, Melanophy G, Doyle C, Bannan C, O'Riordan R, Merry C, Clarke S, Bergin C

doi: 10.1111/bcp.14482.

Viral Infections, Non-HIV

A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in Coronavirus Disease-19 (COVID-19)

Int J Rheum Dis.

Shah S, Das S, Jain A, Misra DP, Negi VS

doi: 10.1111/1756-185X.13842.

Viral Infections, Non-HIV

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

JAMA.

Rosenberg ES, Dufort EM, Udo T, Wilberschied LA, Kumar J, Tesoriero J, Weinberg P, Kirkwood J, Muse A, DeHovitz J, Blog DS, Hutton B, Holtgrave DR, Zucker HA

doi: 10.1001/jama.2020.8630.

Viral Infections, Non-HIV

Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review

Ann Intern Med.

Hernandez AV, Roman YM, Pasupuleti V, Barboza JJ, White CM

doi: 10.7326/M20-2496.

Viral Infections, Non-HIV

Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis

Heart.

Li X, Guan B, Su T, Liu W, Chen M, Bin Waleed K, Guan X, Gary T, Zhu Z

doi: 10.1136/heartjnl-2020-317062.

Viral Infections, Non-HIV

QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin

J Interv Card Electrophysiol.

C Hsia B, Greige N, A Quiroz J, S Khokhar A, Daily J, Di Biase L, J Ferrick K, D Fisher J, Krumerman A

doi: 10.1007/s10840-020-00822-x.

Viral Infections, Non-HIV

Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events

Diabetes Metab Syndr.

Nandy K, Salunke A, Pathak SK, Pandey A, Doctor C, Puj K, Sharma M, Jain A, Warikoo V

doi: 10.1016/j.dsx.2020.06.064.

Related content

Cancer associates with risk and severe events of COVID-19: A systematic review and meta-analysis

Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Clinical outcomes and adverse events in patients hospitalised with COVID -19, treated with off- label hydroxychloroquine and azithromycin

A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in Coronavirus Disease-19 (COVID-19)

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review

Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis

QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin

Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events